findmyKOL

Tarun Wasil, MD

Basic profile

Long Island Jewish Medical Center

ORCIDNone on fileNPI
RegionNew Hyde Park, NY · NortheastSpecialtyHematology / OncologyFocusOncology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2010Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Tarun Wasil is an Oncology physician affiliated with Long Island Jewish Medical Center. OpenAlex indexes 27 publications with 3,797 citations (h-index 10).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
27publications

Distinct works indexed by OpenAlex.

3,797citations

Total citations across indexed works.

10h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
28companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1 Delaware Dr Ste 105
New Hyde Park, NY 110421116

Telephone

516-336-5255

Provider last certified this registry record 2 Dec 2021.

View the NPPES registry record

Industry payments

28 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Blood & clotting

    72.8%
    Iron, parenteral preparations72.3%
    Ferric carboxymaltose100%
    Part B, office-administered31 patients
    Erythropoiesis-stimulating Agent0.3%
    Procrit100%
    Part D19 patients

    + 3 more classes in this area

  • Cancer & immunology

    16.3%
    PD-1 inhibitor14.5%
    Pembrolizumab100%Tecentriq0%
    Part D + Part B<11 patients
    Kinase inhibitor0.3%
    Calquence38%Brukinsa20%Imatinib Mesylate14%Erlotinib Hcl10%Ayvakit9%Retevmo9%
    Part D<11 patients

    + 17 more classes in this area

  • Musculoskeletal

    6.3%
    RANK Ligand Inhibitor6.2%
    Denosumab97%Xgeva2%Prolia1%
    Part D + Part B<11 patients
    Xanthine oxidase inhibitor0.1%
    Allopurinol100%
    Part D19 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”